Skip to main content
An official website of the United States government
Email

MelaNostrum Consortium Members

United States

MelaNostrum Consortium

Department of Health and Human Services
National Institutes of Health
National Cancer Institute, Division of Cancer Epidemiology and Genetics
Maria Teresa Landi (PI)
Kevin Brown

Spain

Barcelona
Melanoma Unit, Hospital Clínic de Barcelona, IDIBAPS
Universitat de Barcelona
Susana Puig (PI)
Paula Aguilera
Llucia Alos
Alicia Barreiro
Cristina Carrera
Natalia Espinosa
Pablo Iglesias
Judit Mateu
Miriam Potrony
Carolina Sánchez
Oriol Yelamos
Beatriz Alejo
Celia Badenas
Abel Caño
Mireia Domínguez
Daniel Gabriel
Josep Malvehy
Maria E Moliner
Joan Anton Puig-Butille
Gemma Tell

València
Instituto Valenciano de Oncología
Eduardo Nagore (PI)
Rajiv Kumar
Zaida Garcia-Casado
Celia Requena Arantxa
Rodriguez-Hernandez
Virtudes Soriano
Víctor Traves

Madrid
Servicio de Dermatología Hospital 12 de Octubre
Pablo Ortiz-Romero (PI)
José Luis Rodríguez-Peralto
Cristina Vico-Alonso

Italy

Cesena
Department of Dermatology Maurizio Bufalini Hospital
Donato Calista (PI)

L'Aquila Department of Dermatology University of L'Aquila
Maria Concetta Fargnoli (PI)
Cristina Pellegrini

Padua
Veneto Institute of Oncology IOV - IRCCS Immunology and Diagnostics Molecular Oncology Unit
Chiara Menin (PI)

Cancer Genomics Program
Arcangela De Nicolo (USA - Europe Liaison Scientist)

Rome
Institute of Dermatology Catholic University - Fondazione Policlinico A. Gemelli
Ketty Peris (PI)
Silvia Catapano
Francesco Federico
Barbara Fossati
Erika Valentina De Luca
Laura Del Regno
Alessandro Di Stefani

San Gallicano Dermatological Institute – IRCCS, IFO
Carlo Cota (PI)
Monia Di Prete (pathologist)
Piera Rizzolo (molecular biologist)

Genoa
University of Genoa
University Hospital Policlinico San Martino Genetics of Rare Cancers
Department of Internal Medicine and Medical Specialties
Paola Ghiorzo (PI)
William Bruno
Giulia Ciccarese
Bruna Dalmasso
Lorenza Pastorino

Medical Oncology Unit
Paola Queirolo

Milan
Department of Experimental Oncology and Molecular Medicine
Fondazione IRCCS Istituto Nazionale dei Tumori
Monica Rodolfo (PI)

Florence
Histopathology and Molecular Diagnostics Careggi University Hospital
Daniela Massi (PI)
Vincenzo De Giorgi

Perugia
Medical Oncology Unit, University of Perugia
Mario Mandala (PI)
Carmen Molica
Roberta La Starza

Greece

Athens
National and Kapodistrian University of Athens
School of Medicine Andreas Sygros Hospital
Alex Stratigos (PI)
Evangelos Evangelou
Helen Gogas
Katerina Kypreou
Irene Stefanaki

Ioannina
Department of Hygiene and Epidemiology
University of Ioannina Medical School
Evangelos Evangelou

Cyprus

Cyprus
Nicosia Department of Electron Microscopy/Molecular Pathology
The Cyprus Institute of Neurology and Genetics
The Cyprus School of Molecular Medicine

France

Nice
Laboratory of Clinical and Experimental Pathology, Nice University Hospital
Nice Hospital-integrated Biobank, University of Côte d'Azur
Paul Hofman (PI)
Elodie Long-Mira

Croatia

Croatia
Department of Dermatology and Venereology, Sestre Milosrdnice University Hospital Centre
School of Dental Medicine, University of Zagreb
Mirna Šitum (PI)
Marija Buljan

Criteria for Membership

For a new PI who is not part of a group already working in the Consortium and potentially bringing with him/her other people from their group:

  • The candidate must contribute data and/or biospecimens from melanoma patients (sporadic and/or familiar and possibly healthy controls) for the Consortium's projects. A brief description of the studies and related material that the candidate can contribute should be made available to all MelaNostrum PIs for their consideration.
  • The candidate must respect absolute confidentiality about any discussion of data/projects within the Consortium. Failure to observe this requirement may result in the exclusion from the Consortium.
  • The candidate can be introduced by an existing member of MelaNostrum who can speak for his/her high quality of work and discretion. A candidate may alternatively approach the Consortium directly with the request to participate, in which case the decision to accept will be determined by the MelaNostrum PIs.
  • The candidate or a person from his/her group should strive to participate in person in each annual meeting.
  • The decision on whether to accept a new member or not should be made collegially by the MelaNostrum PIs. The decision can be communicated to Maria Teresa Landi privately by email and if consensus is not reached and more discussion is required, we could postpone the decision to the Consortium annual meeting.

If the candidate is a member of a group already working in MelaNostrum, it is enough if the PI who invites the person explains why he/she wants to bring this person and the type of expertise that this candidate can bring (e.g. in genetics, statistics, or molecular biology).

Email